Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference
SAN CARLOS, Calif., Sept. 11, 2024 ( GLOBE NEWSWIRE ) -- Vaxcyte, Inc. ( Nasdaq: PCVX ) , a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today that Company management will participate in a ...
| Ticker |
Sentiment |
Impact |
|
PCVX
|
Somewhat Bullish
|
47 %
|
|
STRO
|
Neutral
|
10 %
|
